Concepedia

Jeffrey Alder

JA

Statistics

Publications

7

Citations

279

H-Index

7

Active since

1994

Affiliations

Abbott Fund(Current)

Cubist Pharmaceuticals (United States)

Jeffrey Alder is an author at Abbott Fund specializing in pharmacy, pharmacology, and infectious diseases.

Publications per year

1994–2005

7

Publications

7

In Vitro Bactericidal Activities of Daptomycin against <i>Staphylococcus aureus</i> and <i>Enterococcus faecalis</i> Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis

Valerie A. Laganas, Jeffrey Alder, Jared Silverman · Antimicrobial Agents and Chemotherapy · 2003 · 88 citations · Full text

Life Sciences, Microbiology, Pharmacology +9

The advance of bacterididal drugs in the treatment of infection

Jeffrey Alder, Barry I. Eisenstein · Current Infectious Disease Reports · 2004 · 39 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Total synthesis and antifungal evaluation of cyclic aminohexapeptides

Larry L. Klein, Leping Li, Hui-Ju Chen et al. · Bioorganic & Medicinal Chemistry · 2000 · 37 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +16

Second-Generation Peptidomimetic Inhibitors of Protein Farnesyltransferase Demonstrating Improved Cellular Potency and Significant in Vivo Efficacy

Stephen J. O’Connor, Kenneth J. Barr, Le Wang et al. · Journal of Medicinal Chemistry · 1999 · 37 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis

Jennifer M Streit, Judith N. Steenbergen, Grace M. Thorne et al. · Journal of Antimicrobial Chemotherapy · 2005 · 37 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

1–5 of 7